Medicine. Rosatom has launched two pilot production lines at its new radiopharmaceuticals factory in the Kaluga Region, Russia. The commissioning phase will conclude with the production of test batches to validate that products meet quality requirements. Ramp-up to full capacity is scheduled for 2028. The factory is being built in compliance with EAEU Good Manufacturing Practice (GMP) standards aligned with international norms. It will produce a broad portfolio of radiopharmaceuticals, including those based on radium-223 for the treatment of bone metastases and actinium-225 for targeted cancer therapies. “We will be able to almost fully meet the country’s healthcare needs, which are expected to reach approximately 1.5 million procedures by the end of the decade,” said Pavel Zaitsev, Director General of Rosatom Science JSC. Rosatom currently produces more than ten registered radiopharmaceuticals for diagnostic and therapeutic applications.

Construction sites. Rosatom Director General Alexey Likhachev and Egypt’s Minister of Electricity and Renewable Energy, Mahmoud Esmat, reviewed the progress of construction at the El Dabaa Nuclear Power Plant. Both parties praised the pace of work, highlighting the installation of Unit 2’s reactor pressure vessel in its design position in July. First electricity from the plant is expected to be fed into the grid in 2028. Beyond power generation, the officials discussed expanding cooperation into non-energy sectors, including the construction of a desalination plant and the establishment of nuclear medicine and additive manufacturing centers. El Dabaa will be Egypt’s first nuclear power facility featuring four power units with VVER-1200 reactors, each with a capacity of 1,200 MW.

Cooperation. In Jakarta, representatives of Russia’s nuclear regulator Rostechnadzor, Indonesia’s Nuclear Energy Regulatory Agency (BAPETEN), Rosatom, and the Indonesian Ministry of Transport discussed the development of the regulatory framework for nuclear projects. Special attention was given to the implementation of Floating Nuclear Power Units (FNPUs) projects, taking into account the specifics of deploying them across Indonesia’s island geography, as well as to the exchange of experience between the relevant agencies of the two countries. “Indonesia is steadily developing its nuclear energy sector, and building a reliable and effective regulatory system is one of the key elements of our work. We are interested in deepening our cooperation with Rostechnadzor, exchanging expertise, and studying international regulatory standards,” said Zainal Arifin, Acting Head of BAPETEN.